We created TiO₂ nanotubes (TNTs) on the surface of titanium (Ti) implants with subsequential loading with gentamicin and chitosan, acting as a control release agent, by electrophoretic deposition (EPD). We hypothesized femoral implants with TNTs loaded with gentamicin and chitosan would localize antibiotic to the implant and surgical site and prevent PJI in a mouse model.

Ti-6Al-4V ELI wires underwent TNT surface modification by two-step anodization. EPD was then used to load gentamicin and chitosan onto the Ti wire with surface TNTs. Control Ti wires contained TNTs with EPD of chitosan only. 12-week-old male C57BL/6J mice underwent received a right femoral intramedullary implant followed by inoculation at the surgical site with 1×10³ CFUs of bioluminescent Xen36 Staphylococcus aureus (S. aureus). Mice were randomly divided into two implant groups: 1) Gentamicin + Chitosan Group (n=7; experimental group); 2) Chitosan Group (n=7; control group). Outcomes included: 1) Relative S. aureus abundance by bioluminescence imaging; 2) Quantification of S. aureus at the implant and surrounding tissue by colony forming unit (CFU) analysis; 3) Scanning electron microscopy (SEM) for implant bacterial biofilm; 4) Radiographic signs of PJI.

Over 14 days assessment following wire implantation and inoculation with S. aureus, the experimental group had no evidence of infection based on i) no increased Xen36 S. aureus bioluminescence signal and ii) no CFUs present. All control had increased bioluminescence signal, above baseline, at all time-points and presence of CFUs.

Ti femoral implants modified with surface TNTs and coated with gentamicin and chitosan through EPD prevented PJI in all mice through 14 days. In comparison, all control mice demonstrated evidence of PJI over 14 days. Implants with TNTs and EPD of gentamicin were highly effective in this mouse PJI model.

Introduction

Studies of retrieved total knee replacement (TKR) components demonstrate that in vivo wear on the articular surface of polyethylene liners exhibits a much higher variability than their in vitro counterparts tested on simulators.¹ Only one study has attempted to validate a patient-specific model of wear with a clinically retrieved component.² The purpose of this study is to investigate the relationship between observed TKR contact conditions during gait and measured volume loss on retrieved tibial components.

Background

Aseptic loosening is the leading cause of total knee arthroplasty (TKA) failure in the long term, of which osteolysis from polyethylene wear debris remains a problem that can limit the lifetime of TKA past the second decade. To help speed up design innovations, our goal was to develop a computational framework that could efficiently predict the effect of many sources of variability on TKA wear—including design, surgical, and patient variability.

Introduction

This study explores whether subjects with bicruciate retaining TKRs (BiCR) have more normal knee biomechanics during level walking and stair ascent than subjects with posterior cruciate retaining TKRs (PCR). Due to anterior cruciate ligament (ACL) preservation, we expect BiCR subjects will not show the reduced flexion and altered muscle activation patterns characteristic of persons with TKRs.

Introduction

Bicruciate-retaining (BiCR) total knee replacements (TKRs) were designed to improve implant performance; however, functional advantages during daily activity have yet to be demonstrated. Although level walking is a common way to analyze functionality, it has been shown to be a weak test for identifying gait abnormalities related to ACL pathologies. The goal of this study is to set up a functional motion analysis test that will examine the effects of the ACL in TKR patients by comparing knee kinematics, kinetics, and muscle activation patterns during level and downhill walking for patients with posterior-cruciate retaining (PCR) and BiCR TKRs.